Triamterene	triamterene	O	O	OTHERS	I
nephrolithiasis	nephrolithiasis	O	DISEASE	OTHERS	I
complicating	complicating	O	O	O	O
dyazide	dyazide	O	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
triamterene	triamterene	O	O	OTHERS	I
nephrolithiasis	nephrolithiasis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
man	man	O	O	O	O
after	after	O	O	O	O
4	4	O	O	O	O
years	years	O	O	O	O
of	of	O	O	O	O
hydrochlorothiazide-triamterene	hydrochlorothiazide-triamterene	O	O	O	O
therapy	therapy	O	O	O	O
for	for	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
stone	stone	O	O	O	O
passed	passed	O	O	O	O
spontaneously	spontaneously	O	O	O	O
and	and	O	O	O	O
was	was	O	O	O	O
found	found	O	O	O	O
to	to	O	O	O	O
contain	contain	O	O	O	O
a	a	O	O	O	O
triamterene	triamterene	O	O	OTHERS	I
metabolite	metabolite	O	O	O	O
admixed	admixed	O	O	O	O
with	with	O	O	O	O
uric	uric	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
salts	salts	O	O	OTHERS	I
.	.	O	O	O	O

Factors	factors	O	O	O	O
affecting	affecting	O	O	O	O
triamterene	triamterene	O	O	OTHERS	I
nephrolithiasis	nephrolithiasis	O	DISEASE	OTHERS	I
are	are	O	O	O	O
discussed	discussed	O	O	O	O
and	and	O	O	O	O
2	2	O	O	O	O
previously	previously	O	O	O	O
reported	reported	O	O	O	O
cases	cases	O	O	O	O
are	are	O	O	O	O
reviewed	reviewed	O	O	O	O
.	.	O	O	O	O

